The South Korean disease control authority is requesting the health authority to grant a special approval on 117,000 doses of Pfizer vaccines to be supplied to the country by COVAX Facility.

Under the supply agreement with COVAX Facility, the vaccines would be promptly introduced to South Korea for inoculation starting from this month.

On February 2, Korea Disease Control and Prevention Agency (KDCA) announced it applied for a special import authorization to the Ministry of Food and Drug Safety (MFDS) for the vaccines. The action is based on the results of the COVID-19 Vaccine Expert Council meeting convened by MFDS and KDCA and the Article 85 of the Pharmaceutical Affairs Act.